Valeant Pharmaceuticals International Inc (NYSE:VRX)
During the Trading Day
| 86.41 |  +0.55 / +0.64% |
Data as of 4:05pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 86.51 | +0.102 / +0.12% |
Volume: 6.5K |
Latest VRX News | Press Releases
| Valeant Raising Funds - Analyst Blog 5:26pm / Zacks.com | Valeant Biting More Than it Can Chew Jun 13 / MotleyFool.com |
| 5 Drugs Stocks Driving The Industry Higher 1:14pm / TheStreet.com | Tme to Buy This Defensive Growth Stock? Jun 11 / MotleyFool.com |
| The Top 3 Medical Uses of Botox Jun 18 / MotleyFool.com | This Company is Set for Newer Heights in the Eye-Care Sector Jun 11 / MotleyFool.com |
| UPDATE: Valeant Pharmaceuticals Announces Public Offering Of Common Shares; To Raise ... Jun 17 / Benzinga | Hyperion Acquires Buphenyl Rights - Analyst Blog Jun 10 / Zacks.com |
| Warner Chilcott: Should You Buy Joel Greenblatt's Latest Pick? Jun 13 / MotleyFool.com | 2 Huge Deals as M&A Accelerates Jun 06 / MotleyFool.com |
Today’s Trading
| Previous close | 85.86 |
| Today’s open | 86.20 |
| Day’s range | 85.62 - 87.55 |
| Volume | 8,346,677 |
| Average volume (3 months) | 1,853,307 |
| Market cap | $26.2B |
| Dividend yield | -- |
Data as of 4:05pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -173.08% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +11.50% |
| Revenue growth (last year) | +43.97% |
| P/E ratio | 27.6 |
| Price/Sales | 5.15 |
| Price/Book | 7.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AGNAllergan Inc | -2.21 | -2.18% |
| SHPGShire PLC | -1.60 | -1.63% |
| ALXNAlexion Pharmaceutic... | -1.30 | -1.41% |
| VRTXVertex Pharmaceutica... | -0.93 | -1.18% |
Data as of 4:01pm ET, 06/19/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $3.5B |
| Annual profit (last year) | -$116.0M |
| Net profit margin | -3.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer J. Michael Pearson, MBA |
Chief Financial Officer, Director & Executive VP Howard Bradley Schiller |
Corporate headquarters Montréal, Québec |
Forecasts
